A report from Elsevier shows that research funders are facing significant gaps between their stated priorities and the implementation of such priorities, particularly in aligning funding with societal ...

Elsevier, publisher of science journals and clinical decision-support tools, is rolling out an AI-powered research tool it says is built to transform how researchers work. LeapSpace is an AI-assisted ...

Elsevier Health has launched an generative AI-driven version of its flagship clinical decision support tool, ClinicalKey, in partnership with AI company OpenEvidence. The latest add-on module offers ...

After a year of talks, Dutch publishing giant Elsevier has struck a deal with a group of Norwegian universities that will allow academics to publish the vast majority of their work under open-access ...

The University of California System has canceled its multimillion-dollar subscription contract with Elsevier, an academic publisher. Other institutions have canceled their “big deal” journal ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. In 1995, Forbes, the business magazine, made a prediction: Elsevier, the largest publisher of scientific ...

New generative AI tool on ScienceDirect, the world's largest platform for peer-reviewed research used by millions of researchers each day, saves half of literature research time, supports better ...

Elsevier this week announced its acquisition of Pittsburgh-based Via Oncology, a former subsidiary of UPMC that develops clinical decision support tools for cancer care management. Via Oncology's ...

Ron Mobed, the CEO of the scientific, technical and medical information business Elsevier, is a long term thinker in a digital first environment – a space that isn’t generally known for extensive and ...

Academic publishing is a very good game indeed if you can manage to get into it. As the publisher the work is created at the expense of others, for free to you. There are no advances, no royalties, to ...

A scholarly journal run by the Dutch publishing giant Elsevier has come under scrutiny for rejecting a paper submitted for publication because, among other reasons, it didn’t cite enough of the ...